The effect of dopamine agonists on metabolic variables in adults with type 2 diabetes: A systematic review with meta analysis and trial sequential analysis of randomized clinical trials.

Ida Brandt AndersenMikkel AndreassenJesper Krogh

Published in: Diabetes, obesity & metabolism (2020)

Dopamine agonists reduce HbA1c as well as fasting plasma glucose and triglycerides in patients with type 2 diabetes without causing SAEs. These data are based on moderate to low quality evidence thus our confidence in the effect estimates is limited.

Keyphrases

blood glucose
uric acid
study protocol
electronic health record
clinical trial
phase iii
insulin resistance
high intensity
phase ii
big data
metabolic syndrome
randomized controlled trial
quality improvement
high density
type diabetes
adipose tissue
data analysis
artificial intelligence
deep learning